Cargando…

Multigene Panel Testing in Turkish Hereditary Cancer Syndrome Patients

OBJECTIVE: Hereditary cancer syndromes (HCSs) are a heterogenous group of disorders caused by germline pathogenic variations in various genes that function in cell growth and proliferation. This study aimed to describe the germline variations in patients with hereditary cancer using multigene panels...

Descripción completa

Detalles Bibliográficos
Autores principales:	ARSLAN ATES, Esra, TURKYILMAZ, Ayberk, ALAVANDA, Ceren, YILDIRIM, Ozlem, GUNEY, Ahmet Ilter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234359/ https://www.ncbi.nlm.nih.gov/pubmed/35734982 http://dx.doi.org/10.4274/MMJ.galenos.2022.22556

Ejemplares similares

miR-34a-FOXP1 Loop in Ovarian Cancer
por: Dirimtekin, Esra, et al.
Publicado: (2023)

Application of Multigene Panels Testing for Hereditary Cancer Syndromes
por: Bilyalov, Airat, et al.
Publicado: (2022)

Multigene Panel Testing for Hereditary Cancer Risk
por: Grissom, Alyssa A., et al.
Publicado: (2016)

Genetic and Clinical Characterization of Patients with Maturity-Onset of Diabetes of the Young (MODY): Identification of Novel Variations
por: Arslan Ateş, Esra, et al.
Publicado: (2021)

The Cost-Effectiveness of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in Norway
por: Asphaug, Lars, et al.
Publicado: (2019)

Mutation prevalence tables for hereditary cancer derived from multigene panel testing
por: Hart, Steven N., et al.
Publicado: (2020)

Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing
por: Shimelis, Hermela, et al.
Publicado: (2018)

Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer
por: Yadav, Siddhartha, et al.
Publicado: (2020)

Hereditary Gastric Cancer: Single-Gene or Multigene Panel Testing? A Mono-Institutional Experience
por: Calvello, Mariarosaria, et al.
Publicado: (2023)

Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer
por: Ryu, Jin‐Sun, et al.
Publicado: (2020)

Cancer Risk Associated With PTEN Pathogenic Variants Identified Using Multigene Hereditary Cancer Panel Testing
por: Cummings, Shelly, et al.
Publicado: (2023)

Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients
por: LaDuca, Holly, et al.
Publicado: (2014)

Genetic Variation and the Role of Multigene Panel Testing for Hereditary Breast Cancer: A Single-Institution Experience
por: Lu, Kit, et al.
Publicado: (2021)

Validation of the Turkish Version of the Sexual Health Outcomes in Women Questionnaire (SHOW-Q) in Turkish-Speaking Women
por: Selcuk, Selcuk, et al.
Publicado: (2016)

Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes
por: Hu, Chunling, et al.
Publicado: (2018)

Optimizing the identification of risk‐relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families
por: Coppa, Anna, et al.
Publicado: (2017)

The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
por: Eliade, Marie, et al.
Publicado: (2016)

Novel genetic mutations detected by multigene panel are associated with hereditary colorectal cancer predisposition
por: Martin-Morales, Lorena, et al.
Publicado: (2018)

Increased Co-Occurrence of Pathogenic Variants in Hereditary Breast and Ovarian Cancer and Lynch Syndromes: A Consequence of Multigene Panel Genetic Testing?
por: Infante, Mar, et al.
Publicado: (2022)

Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing
por: Zhang, Zeng-Yun-Ou, et al.
Publicado: (2021)

Germline multigene panel testing of patients with endometrial cancer
por: Kral, Jan, et al.
Publicado: (2023)

Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer
por: Hamilton, Jada G., et al.
Publicado: (2021)

Importance of multigene panel test in patients with consanguineous marriage and family history of breast cancer
por: Ozmen, Vahit, et al.
Publicado: (2022)

When do we need to suspect maturity onset diabetes of the young in patients with type 2 diabetes mellitus?
por: Üstay, Özlem, et al.
Publicado: (2022)

Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer
por: Elsayegh, Nisreen, et al.
Publicado: (2018)

The Benefit of Multigene Panel Testing for the Diagnosis and Management of the Genetic Epilepsies
por: Leduc-Pessah, Heather, et al.
Publicado: (2022)

Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer
por: Lhotova, Klara, et al.
Publicado: (2020)

Integration of multigene panels for the diagnosis of hereditary retinal disorders using Next Generation Sequencing and bioinformatics approaches
por: Di Resta, Chiara, et al.
Publicado: (2018)

Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition
por: Tedaldi, Gianluca, et al.
Publicado: (2019)

TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel Testing
por: Lesueur, Fabienne, et al.
Publicado: (2021)

The prevalence of dental anomalies in a turkish population
por: Aren, Gamze, et al.
Publicado: (2015)

Multigene panel predicting survival of patients with colon cancer
por: Li, Hao-Dong, et al.
Publicado: (2019)

Detection of BRCA1 Pathogenic Variant in a 24-Year-Old Endometrial Cancer Patient: Risks of Several Hereditary Tumor Syndromes Assessed Using Germline Multigene Panel Testing
por: Wang, Xiaofei, et al.
Publicado: (2022)

Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore
por: Wong, Edward S Y, et al.
Publicado: (2016)

Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients
por: Tedaldi, Gianluca, et al.
Publicado: (2020)

Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations
por: Horton, Carolyn, et al.
Publicado: (2022)

Detection of germline variants in Brazilian breast cancer patients using multigene panel testing
por: Guindalini, Rodrigo Santa Cruz, et al.
Publicado: (2022)

Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology
por: Valentini, Virginia, et al.
Publicado: (2023)

Identification of Lynch Syndrome in Patients with Endometrial Cancer Based on a Germline Next Generation Sequencing Multigene Panel Test
por: Kim, Yoo-Na, et al.
Publicado: (2022)

Integrated multigene expression panel to prognosticate patients with gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n4i5vjfkqfcrnk27thsmtqh6jd